Ask Google

Results for a102 translation from German to English

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

German

English

Info

German

Location: A102, Spl.

English

Location: SR 01-018, Geb. 101

Last Update: 2018-02-13
Usage Frequency: 1
Quality:

German

Zurückweisung A102(2)

English

Rules of Procedure A23(4); R11(2)

Last Update: 2018-02-13
Usage Frequency: 1
Quality:

German

Änderung A102(3) , A123

English

balance sheet A49(1),(3)

Last Update: 2018-02-13
Usage Frequency: 1
Quality:

German

Hinweise für die Zahlung von Gebühren, Auslagen und Verkaufspreisen A102 PDF View

English

Guidance for the payment of fees, expenses and prices A102 PDF View

Last Update: 2018-02-13
Usage Frequency: 1
Quality:

German

A102 Ein Beispiel für die Absicherung des beizulegenden Zeitwerts ist die Absicherung des Risikos aus einer Änderung des beizulegenden Zeitwerts eines festverzinslichen Schuldinstruments aufgrund einer Zinsänderung.

English

AG102 An example of a fair value hedge is a hedge of exposure to changes in the fair value of a fixed rate debt instrument as a result of changes in interest rates.

Last Update: 2016-12-04
Usage Frequency: 1
Quality:

Reference: MatteoT

German

Bei der Ausfahrt 7 auf der m25 fahren Sie auf die a12 in den Blackwall Tunnel. Wenn Sie herauskommen aus dem Tunnel bleiben Sie auf dieser Strasse a102 bis Sie Schilder in Richtung a2 Central London sehen.

English

- Take the A12 to the Blackwall Tunnel. - When you come through the Blackwall Tunnel, continue on this road (A102) until you see an exit signposted A2 Central London.

Last Update: 2018-02-13
Usage Frequency: 1
Quality:

Reference: MatteoT

German

Entrichtung A97(2)b) , A97(3) , A102(3)b) (4) ; R51(4) (8) , R58(5) (6)

English

non-prejudicial ~ A55; R23 of the invention A83; R28(1) summary of the ~ R33(2) discoveries

Last Update: 2018-02-13
Usage Frequency: 1
Quality:

Reference: MatteoT

German

Entscheidungen A102(1) - (3) , A116(4) ; R56(2) , R58(8)

English

fees A76(3); R6(1), R25(2), R37(3); RFees10

Last Update: 2018-02-13
Usage Frequency: 1
Quality:

Reference: MatteoT

German

71 Besteht zwischen einem Sicherungsinstrument und einem in den Paragraphen 85-88 und Anhang A Paragraphen A102-A104 beschriebenen gesicherten Grundgeschäft eine designierte Sicherungsbeziehung, so werden die Gewinne und Verluste aus dem Sicherungsinstrument und dem gesicherten Grundgeschäft nach den Paragraphen 89-102 bilanziert.

English

71 If there is a designated hedging relationship between a hedging instrument and a hedged item as described in paragraphs 85-88 and Appendix A paragraphs AG102-AG104, accounting for the gain or loss on the hedging instrument and the hedged item shall follow paragraphs 89-102.

Last Update: 2016-10-08
Usage Frequency: 1
Quality:

Reference: MatteoT

German

Verfahren nach Anspruch 1 oder Anspruch 2, bei dem der Schritt (A10) weiterhin die Schritte aufweist: (A101) Sortieren jeweiliger erster Kreuzungspunktdaten (D ) für die ersten Kreuzungspunkte (C ) entsprechend jeweiliger Hauptabtast-Koordinatenwerte erster Kreuzungspunktdaten (D ), um die sortierten ersten Kreuzungspunktdaten (D ) in einer zweiten Speichereinrichtung zu speichern, und (A102) serielles Auslesen der sortierten ersten Kreuzungspunktdaten (D ) aus der zweiten Speichereinrichtung in der Reihenfolge entlang der Abtastlinie, um seriell den ersten Objektpunkt zu schaffen; und der Schritt (A11) weiterhin die Schritte aufweist: (A111) Sortieren jeweiliger zweiter Kreuzungspunktdaten (D ) für die zweiten Kreuzungspunkte (CP ) entsprechend jeweiliger Hauptabtast-Koordinatenwerte in den zweiten Kreuzungspunktdaten (D ), um die sortierten zweiten Kreuzungspunktdaten (D ) in einer dritten Speichereinrichtung zu speichern, und (A112) serielles Auslesen der sortierten zweiten Kreuzungspunktdaten (D ) aus der dritten Speichereinrichtung in der Reihenfolge entlang der Abtastlinie, um seriell den zweiten Objektpunkt zu schaffen.

English

A method according to Claim 1 or Claim 2, wherein the step (A10) further comprises the steps of: (A101) sorting respective first cross point data (D ) for said first cross points (C ) according to respective main scanning coordinate values of said first cross point data (D ) to store the sorted first cross point data (D ) in a second memory means, and (A102) serially reading out said sorted first cross point data (D ) from said second memory means in order along said scanning line to serially provide said first object point, and the step (A11) further comprises the steps of: (A111) sorting respective second cross point data (D ) for said second cross points (CP ) according to respective main scanning coordinate values in said second cross point data (D ) to store the sorted second cross point data (D ) in a third memory means, and (A112) serially reading out said sorted second cross point data (D ) from said third memory means in said order along said scanning line to serially provide said seocnd object point.

Last Update: 2014-12-05
Usage Frequency: 1
Quality:

Reference: MatteoT

German

Verbindung nach Anspruch 1, die aus den folgenden Verbindungen ausgewählt ist, sowie pharmazeutisch annehmbare Salze, Hydrate und Solvate davon: (A1) 1-[6-(4-Imidazol-1-ylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäure-ethylester; (A2) 1-[6-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A3) 1-[6-(4-Methansulfonylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A5) 1-{6-[4-(2-Methoxycarbonylacetyl)phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A6) 1-[5-Amino-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A7) 1-[6-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-(2,2,2-trifluoracetylamino)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A8) Propionsäure-1-[2-amino-5-formyl-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)pyrimidin-4-yl]piperidin-4-ylester; (A10) 1-[6-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäuremethylester; (A12) 1-[6-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]piperidin-3-carbonsäureethylester; (A13) 1-[6-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylamid; (A14) 1-[6-(2-Methyl-5-phenyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]-piperidin-4-carbonsäureethylester; (A19) 1-[5-Brom-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A20) 1-[5-Acetylamino-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A21) 1-[5-Diacetylamino-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A22) 1-[6-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]-piperidin-4-carbonsäure; (A25) 1-[5-Di-(Methansulfonyl)amino-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yl-oxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A26) 1-[5-Nitro-6-(3-trifluormethylphenoxy)-pyrimidin-4-yl]-piperidin-4-carbonsäureethylester; (A27) 1-[5-Methyl-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A28) 1-[5-Nitro-6-(2-trifluormethylphenoxy)pyrimidin-4-yl]-piperidin-4-carbonsäureethylester; (A29) 1-[5-Nitro-6-(4-trifluormethylphenoxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A30) 1-[6-(4-Fluorphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A31) 1-[6-(2,5-Dimethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A32) 1-[6-(4-Bromphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A33) 1-[6-(4-Chlorphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A34) 1-[6-(4-Carbamoylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A35) 1-{6-[4-(2-Methoxyethyl)phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A36) 1-[6-(4-Cyclopentylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A37) 1-[5-Nitro-6-(4-pyrrol-1-ylphenoxy)-pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A38) 1-[6-(4-Benzoylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A39) 1-{6-[4-(4-Hydroxybenzolsulfonyl)phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A40) 1-[6-(4'-Cyanobiphenyl-4-yloxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A41) 1-[6-(2-Amino-4-ethansulfonylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A42) 1-{6-[4-(5-Hydroxypyrimidin-2-yl)-phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A43) 1-[5-Nitro-6-(4-sulfophenoxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A44) 1-[5-Nitro-6-(4-[1,2,4]triazol-1-yl-phenoxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A45) 1-[6-(4-Carbamoylmethylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A46) 1-{6-[4-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A47) 1-[6-(4'-Methoxybiphenyl-4-yloxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A48) 1-{6-[4-(2,5-Dioxoimidazolidin-4-yl)-phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A49) 4-(4,4-Difluorpiperidin-1-yl)-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin; (A50) 1-{5-Nitro-6-[4-(4-oxocyclohexyl)phenoxy]pyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A51) 1-{5-Nitro-6-[4-(3-oxo-butyl)-phenoxy]pyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A52) 1-[5-Nitro-6-(4-propionylphenoxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A53) 1-[5-Nitro-6-(4-[1,2,3]thiadiazol-4-yl-phenoxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A54) 1-{6-[4-(2-Hydroxyethyl)phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A55) {4-[6-(4,4-Difluorpiperidin-1-yl)-5-nitropyrimidin-4-yloxy]phenyl}phenylmetha- non; (A56) 3-{4-[6-(4,4-Difluorpiperidin-1-yl)-5-nitropyrimidin-4-yloxy]phenyl}-3-oxo-propionsäuremethylester; (A57) 2-[6-(4,4-Difluorpiperidin-1-yl)-5-nitropyrimidin-4-yloxy]-5-ethansulfonylphenylamin; (A58) 4-(4-Cyclopentylphenoxy)-6-(4,4-difluorpiperidin-1-yl)-5-nitropyrimidin; (A59) 1-[6-(2,6-Dichlor-4-methansulfonylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A60) 1-{6-[4-(4-Chlorbenzoyl)phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A61) 1-{6-[4-(4-Hydroxybenzoyl)phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A62) 1-[6-(4-Cyanomethylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A66) 4-(4-Methylpiperidin-1-yl)-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin; (A67) 4-(4-Brompiperidin-1-yl)-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin; (A68) 4-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitro-6-(4-propylpiperidin-1-yl)pyrimidin; (A69) 1-[6-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureamid; (A70) 1-[5-Nitro-6-(2-oxo-2H-chromen-6-yloxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A71) 1-[5-Nitro-6-(2-oxobenzo[1,3]oxathiol-6-yloxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A74) 1-{5-Amino-6-[4-(3-oxobutyl)phenoxy]pyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A75) 1-[6-[4-(3-Oxobutyl)phenoxy]-5-(2,2,2-trifluoracetylamino)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A76) 1-{5-Amino-6-[4-(hydroxyphenylmethyl)phenoxy]pyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A77) 1-[6-(2-Benzoyl-5-methoxyphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A78) 1-[6-(6-Chlorpyridin-3-yloxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A79) 1-[6-(Benzo[1,3]dioxol-5-yloxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A80) 1-[6-(4-Benzyloxyphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A81) 1-[6-(3-Morpholin-4-ylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A82) 1-[5-Nitro-6-(4-trifluormethylsulfanylphenoxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A83) 1-[5-Nitro-6-(4-trifluormethoxyphenoxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A84) 1-[6-(4-Benzoylphenoxy)-5-(2,2,2-trifluoracetylamino)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A85) {4-[5-Nitro-6-(4-propylpiperidin-1-yl)-pyrimidin-4-yloxy]phenyl}phenylmethanon; (A86) {4-Methoxy-2-[5-nitro-6-(4-propylpiperidin-1-yl)pyrimidin-4-yloxy]phenyl}phenylmethanon; (A87) 4-{4-[5-Nitro-6-(4-propylpiperidin-1-yl)pyrimidin-4-yloxy]phenyl}butan-2-on; (A88) 5-Nitro-4-(4-propylpiperidin-1-yl)-6-(4-[1,2,3]thiadiazol-4-yl-phenoxy)pyrimidin; (A89) 3-{4-[5-Nitro-6-(4-propylpiperidin-1-yl)pyrimidin-4-yloxy]phenyl}-3-oxo-propionsäuremethylester; (A90) 5-Ethansulfonyl-2-[5-nitro-6-(4-propylpiperidin-1-yl)pyrimidin-4-yloxy]-phenylamin; (A94) 2-{1-[6-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]-piperidin-4-yl}ethanol; (A95) 3-{1-[6-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]-piperidin-4-yl}propionsäure; (A96) 4-[4-(4-Methylbenzyl)-piperidin-1-yl]-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin; (A97) 4-(3-Methansulfonylpyrrolidin-1-yl)-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin; (A98) 4-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitro-6-[4-(2-trifluormethylphenoxy)piperidin-1-yl]pyrimidin; (A99) 4-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitro-6-[4-(pyridin-2-ylsulfanyl)piperidin-1-yl]pyrimidin; (A100) 4'-(4-Benzoylphenoxy)-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carbonsäureethylester; (A101) 3'-Nitro-4'-[4-(3-oxobutyl)phenoxy]-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carbonsäureethylester; (A102) 4'-[4-(2-Methoxycarbonylacetyl)phenoxy]-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carbonsäureethylester; (A103) 4'-(2-Amino-4-ethansulfonylphenoxy)-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']-bipyridinyl-4-carbonsäureethylester; (A104) 4'-(4-Imidazol-1-ylphenoxy)-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carbonsäureethylester; (A105) 4-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitro-6-(4-trifluormethylpiperidin-1-yl)pyrimidin; (A106) 4-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitro-6-(4-phenylsulfanyl-piperidin-1-yl)pyrimidin; (A107) 1-[6-(3-Acetylenylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A108) 1-[6-(4-Chlor-2-fluorphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A109) 1-[6-(2,4-Difluorphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A110) 1-[6-(4-Brom-2-fluorphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A111) 4-(3-Acetylenylphenoxy)-5-nitro-6-(4-propylpiperidin-1-yl)pyrimidin; (A112) 4-(4-Chlor-2-fluorphenoxy)-5-nitro-6-(4-propylpiperidin-1-yl)pyrimidin; (A113) 4-(2,4-Difluorphenoxy)-5-nitro-6-(4-propylpiperidin-1-yl)pyrimidin; (A114) 4-(4-Brom-2-fluorphenoxy)-5-nitro-6-(4-propylpiperidin-1-yl)pyrimidin; (A115) 3'-Nitro-2'-[4-(3-oxo-butyl)-phenoxy]-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-4-carbonsäureethylester; (A116) 4-[4-(3'-Nitro-4-propyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-yloxy)phenyl]butan-2-on; (A117) 2'-(4-Benzoylphenoxy)-3'-nitro-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-4-carbonsäureethylester; (A118) 4-(4-{5-Nitro-6-[4-(pyridin-2-ylsulfanyl)piperidin-1-yl]pyrimidin-4-yloxy}phenyl)butan-2-on; (A119) [4-(3'-Nitro-4-propyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-yloxy)phenyl]phenylmethanon; (A120) 4-(4-{5-Nitro-6-[4-(2-trifluormethylphenoxy)piperidin-1-yl]pyrimidin-4-yloxy}phenyl)butan-2-on; (A121) 4-(4-{6-[4-(3-Methyl-[1,2,4]oxadiazol-5-yl)piperidin-1-yl]-5-nitropyrimidin-4-yloxy}phenyl)butan-2-on; (A122) (4-{6-[4-(3-Methyl-[1,2,4]oxadiazol-5-yl)piperidin-1-yl]-5-nitropyrimidin-4-yloxy}phenyl)phenylmethanon; (A123) 1-{6-[4-(4-Fluorbenzoyl)phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-carbonsäureethylester; (A124) (4-Fluorphenyl)-{4-[5-nitro-6-(4-propylpiperidin-1-yl)pyrimidin-4-yloxy]phenyl}methanon; (A125) 4-[4-(3-Methyl-[1,2,4]oxadiazol-5-yl)piperidin-1-yl]-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin; (A126) 4-(4-Methoxymethylpiperidin-1-yl)-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin; (A127) 4-{4-[6-(4-Methoxymethylpiperidin-1-yl)-5-nitropyrimidin-4-yloxy]phenyl}butan-2-on; (A128) 4-[4-(2-Methoxyethyl)piperidin-1-yl]-6-(2-methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin; (A129) 4-{4-[6-(4-Ethoxymethylpiperidin-1-yl)-5-nitropyrimidin-4-yloxy]-phenyl}butan-2-on; (A130) 4-(2,4-Difluorphenoxy)-5-nitro-6-[4-(pyridin-2-ylsulfanyl)-piperidin-1-yl]pyrimidin; (A131) (4-Methoxy-2-{5-nitro-6-[4-(pyridin-2-ylsulfanyl)-piperidin-1-yl]-pyrimidin-4-yloxy}phenyl)phenylmethanon; (A132) 4-(2,4-Difluorphenoxy)-6-(4-ethoxymethylpiperidin-1-yl)-5-nitropyrimidin; (A133) 4-{4-[6-(4-Cyclopropylmethoxymethylpiperidin-1-yl)-5-nitropyrimidin-4-yloxy]phenyl}butan-2-on; (A134) 4-{4-[5-Nitro-6-(4-propoxymethylpiperidin-1-yl)pyrimidin-4-yloxy]phenyl}butan-2-on; (A135) 1-{4-[6-(4-Methoxymethylpiperidin-1-yl)-5-nitropyrimidin-4-yloxy]phenyl}-ethanon; (A136) 4-{4-[2-Nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl}butan-2-on; (A137) 1-{4-[2-Nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl}ethanon; (A138) {4-[2-Nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl}phenylmethanon; (A139) 3-{4-[2-Nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl}-3-oxo-propionsäuremethylester; (A140) 4-{4-[6-(4-Butoxymethylpiperidin-1-yl)-5-nitropyrimidin-4-yloxy]phenyl}butan-2-on; (A141) 4-{4-[6-(4-Isobutoxymethylpiperidin-1-yl)-5-nitropyrimidin-4-yloxy]phenyl}butan-2-on; (A142) (4-Fluorphenyl)-[4-(3'-nitro-4-propyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-yloxy)phenyl]methanon; (A143) 4-[4-(3'-Nitro-4-propyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-yloxy)phenyl]butan-2-on; (A144) 3'-Nitro-4-propyl-4'-(4-[1,2,4]triazol-1-ylphenoxy)-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl; (A145) 1-{2-Nitro-3-[4-(3-oxo-butyl)phenoxy]phenyl}piperidin-4-carbonsäureethylester; (A146) 1-[3-(4-Benzoylphenoxy)-2-nitrophenyl]piperidin-4-carbonsäureethylester; (A147) {4-[6-(4-Ethoxypiperidin-1-yl)-5-nitropyrimidin-4-yloxy]phenyl}-(4-fluorphenyl)methanon; (A148) 1-[6-(2-Methyl-5-trifluormethyl-2H-pyrazol-3-yloxy)-5-nitropyrimidin-4-yl]piperidin-4-ol; (A149) 1-[6-(4-Acetylphenoxy)-5-nitropyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A150) (1-{6-[4-(4-Fluorbenzoyl)phenoxy]-5-nitropyrimidin-4-yl}piperidin-4-yl)-(4-fluorphenyl-methanon; (A151) 4-(4-{6-[4-(4-Fluorbenzoyl)piperidin-1-yl]-5-nitropyrimidin-4-yloxy}phenyl)-butan-2-on; (A152) 4-(4-Methansulfonylphenoxy)-5-nitro-6-[4-(pyridin-2-ylsulfanyl)piperidin-1-yl]pyrimidin; (A153) 4-(4-Methansulfonylphenoxy)-5-nitro-6-[4-(pyridin-4-ylsulfanyl)-piperidin-1-yl]pyrimidin; (A91) 4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-1-yl]-6-(4-methansulfonylphenoxy)pyrimidin-5-carbonitril; (A155) 1-[5-Nitro-6-(4-trifluormethylsulfanylphenoxy)pyrimidin-4-yl]piperidin-4-carbonsäureethylester; (A156) 5-[1,3]Dioxolan-2-yl-4-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-1-yl]-6-(4-methansulfonylphenoxy)pyrimidin; (A157) 4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-methansulfonylphenoxy)pyrimidin-5-carbaldehyd; (A158) 5-[1,3]Dioxolan-2-yl-4-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-1-yl]-6-(4-[1,2,3]thiadiazol-4-yl-phenoxy)pyrimidin; (A159) 4-[4-(3-Isopropy)-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-[1,2,3]thiadiazol-4-ylphenoxy)pyrimidin-5-carbaldehyd; (A161) [4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-[1,2,3]thiadiazol-4-ylphenoxy)pyrimidin-5-yl]methanol; (A162) [4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-[1,2,3]thiadiazol-4-ylphenoxy)pyrimidin-5-ylmethyl]dimethylamin; (A154) 4-(4-Methansulfonylphenoxy)-5-nitro-6-(4-phenylsulfanylpiperidin-1-yl)pyrimidin; (A163) 4-[4-(3-tert-Butyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(6-methansulfonylpyridin-3-yloxy)-5-nitropyrimidin; (A164) 4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-methansulfonylphenoxy)-2-methylpyrimidin-5-carbonitril; und (A165) 1-[4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-methansulfonylphenoxy)pyrimidin-5-yl]ethanon.

English

A compound according to claim 1, selected from the following compounds and pharmaceutically acceptable salts, hydrates, and solvates thereof: (A1) 1-[6-(4-Imidazol-1-yl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A2) 1-[6-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A3) 1-[6-(4-Methanesulfonyl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A5) 1-{6-[4-(2-Methoxycarbonyl-acetyl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A6) 1-[5-Amino-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A7) 1-[6-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-(2,2,2-trifluoro-acetylamino)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A8) Propionic acid 1-[2-amino-5-formyl-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-pyrimidin-4-yl]-piperidin-4-yl ester; (A10) 1-[6-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid methyl ester; (A12) 1-[6-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-3-carboxylic acid ethyl ester; (A13) 1-[6-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethylamide; (A14) 1-[6-(2-Methyl-5-phenyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A19) 1-[5-Bromo-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A20) 1-[5-Acetylamino-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A21) 1-[5-Diacetylamino-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A22) 1-[6-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid; (A25) 1-[5-Di-(methanesulfonyl)amino-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A26) 1-[5-Nitro-6-(3-trifluoromethyl-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A27) 1-[5-Methyl-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A28) 1-[5-Nitro-6-(2-trifluoromethyl-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A29) 1-[5-Nitro-6-(4-trifluoromethyl-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A30) 1-[6-(4-Fluoro-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A31) 1-[6-(2,5-Dimethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; A32) 1-[6-(4-Bromo-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A33) 1-[6-(4-Chloro-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A34) 1-[6-(4-Carbamoyl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A35) 1-{6-[4-(2-Methoxy-ethyl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A36) 1-[6-(4-Cyclopentyl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A37) 1-[5-Nitro-6-(4-pyrrol-1-yl-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A38) 1-[6-(4-Benzoyl-phenoxy)-5-nitro-pyrimidin-4-ylj-piperidine-4-carboxylic acid ethyl ester; (A39) 1-{6-[4-(4-Hydroxy-benzenesulfonyl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A40) 1-[6-(4'-Cyano-biphenyl-4-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A41) 1-[6-(2-Amino-4-ethanesulfonyl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A42) 1-{6-[4-(5-Hydroxy-pyrimidin-2-yl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A43) 1-[5-Nitro-6-(4-sulfo-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A44) 1-[5-Nitro-6-(4-[1,2,4]triazol-1-yl-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A45) 1-[6-(4-Carbamoylmethyl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A46) 1-{6-[4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A47) 1-[6-(4'-Methoxy-biphenyl-4-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A48) 1-{6-[4-(2,5-Dioxo-imidazolidin-4-yl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A49) 4-(4,4-Difluoro-piperidin-1-yl)-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidine; (A50) 1-{5-Nitro-6-[4-(4-oxo-cyclohexyl)-phenoxy]-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A51) 1-{5-Nitro-6-[4-(3-oxo-butyl)-phenoxy]-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A52) 1-[5-Nitro-6-(4-propionyl-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A53) 1-[5-Nitro-6-(4-[1,2,3]thiadiazol-4-yl-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A54) 1-{6-[4-(2-Hydroxy-ethyl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A55) {4-[6-(4,4-Difluoro-piperidin-1-yl)-5-nitro-pyrimidin-4-yloxy]-phenyl}-phenyl-methanone; (A56) 3-{4-[6-(4,4-Difluoro-piperidin-1-yl)-5-nitro-pyrimidin-4-yloxy]-phenyl}-3-oxo-propionic acid methyl ester; (A57) 2-[6-(4,4-Difluoro-piperidin-1-yl)-5-nitro-pyrimidin-4-yloxy]-5-ethanesulfonyl-phenylamine; (A58) 4-(4-Cyclopentyl-phenoxy)-6-(4,4-difluoro-piperidin-1-yl)-5-nitro-pyrimidine; - (A59) 1-[6-(2,6-Dichloro-4-methanesulfonyl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A60) 1-{6-[4-(4-Chloro-benzoyl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A61) 1-{6-[4-(4-Hydroxy-benzoyl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A62) 1-[6-(4-Cyanomethyl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A66) 4-(4-Methyl-piperidin-1-yl)-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidine; (A67) 4-(4-Bromo-piperidin-1-yl)-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidine; (A68) 4-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-6-(4-propyl-piperidin-1-yl)-pyrimidine; (A69) 1-[6-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid amide; (A70) 1-[5-Nitro-6-(2-oxo-2H-chromen-6-yloxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A71) 1-[5-Nitro-6-(2-oxo-benzo[1,3]oxathiol-6-yloxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A74) 1-{5-Amino-6-[4-(3-oxo-butyl)-phenoxy]-pyrimidin-4-yi}-piperidine-4-carboxylic acid ethyl ester; (A75) 1-[6-[4-(3-Oxo-butyl)-phenoxy]-5-(2,2,2-trifluoro-acetylamino)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A76) 1-{5-Amino-6-[4-(hydroxy-phenyl-methyl)-phenoxy]-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A77) 1-[6-(2-Benzoyl-5-methoxy-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A78) 1-[6-(6-Chloro-pyridin-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A79) 1-[6-(Benzo[1,3]dioxol-5-yloxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A80) 1-[6-(4-Benzyloxy-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A81) 1-[6-(3-Morpholin-4-yl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A82) 1-[5-Nitro-6-(4-trifluoromethylsulfanyl-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A83) 1-[5-Nitro-6-(4-trifluoromethoxy-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A84) 1-[6-(4-Benzoyl-phenoxy)-5-(2,2,2-trifluoro-acetylamino)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A85) {4-[5-Nitro-6-(4-propyl-piperidin-1-yl)-pyrimidin-4-yloxy]-phenyl}-phenyl-methanone; (A86) {4-Methoxy-2-[5-nitro-6-(4-propyl-piperidin-1-yl)-pyrimidin-4-yloxy]-phenyl}-phenyl-methanone; (A87) 4-{4-[5-Nitro-6-(4-propyl-piperidin-1-yl)-pyrimidin-4-yloxy]-phenyl)-butan-2-one; (A88) 5-Nitro-4-(4-propyl-piperidin-1-yl)-6-(4-[1,2,3]thiadiazol-4-yl-phenoxy)-pyrimidine; (A89) 3-(4-[5-Nitro-6-(4-propyl-piperidin-1-yi)-pyrimidin-4-yloxy]-phenyl)-3-oxo-propionic acid methyl ester; (A90) 5-Ethanesulfonyl-2-[5-nitro-6-(4-propyl-piperidin-1-yl)-pyrimidin-4-yloxy]-phenylamine; (A94) 2-{1-[6-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidin-4-yl}-ethanol; (A95) 3-{1-[6-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidin-4-yl}-propionic acid; (A96) 4-[4-(4-Methyl-benzyl)-piperidin-1-yl]-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidine; (A97) 4-(3-Methanesulfonyl-pyrrolidin-1-yl)-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidine; (A98) 4-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-6-[4-(2-trifluoromethyl-phenoxy)-piperidin-1-yl]-pyrimidine; (A99) 4-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-6-[4-(pyridin-2-ylsulfanyl)-piperidin-1-yl]-pyrimidine; (A100) 4'-(4-Benzoyl-phenoxy)-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carboxylic acid ethyl ester; (A101) 3'-Nitro-4'-[4-(3-oxo-butyl)-phenoxy]-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carboxylic acid ethyl ester; (A102) 4'-[4-(2-Methoxycarbonyl-acetyl)-phenoxy]-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carboxylic acid ethyl ester; (A103) 4'-(2-Amino-4-ethanesulfonyl-phenoxy)-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carboxylic acid ethyl ester; (A104) 4'-(4-Imidazol-1-yl-phenoxy)-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carboxylic acid ethyl ester; (A105) 4-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-6-(4-trifluoromethyl-piperidin-1-yl)-pyrimidine; (A106) 4-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-6-(4-phenylsulfanyl-piperidin-1-yl)-pyrimidine; (A107) 1-[6-(3-Ethynyl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A108) 1-[6-(4-Chloro-2-fluoro-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A109) 1-[6-(2,4-Difluoro-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A110) 1-[6-(4-Bromo-2-fluoro-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A111) 4-(3-Ethynyl-phenoxy)-5-nitro-6-(4-propyl-piperidin-1-yl)-pyrimidine; (A112) 4-(4-Chloro-2-fluoro-phenoxy)-5-nitro-6-(4-propyl-piperidin-1-yl)-pyrimidine; (A113) 4-(2,4-Difluoro-phenoxy)-5-nitro-6-(4-propyl-piperidin-1-yl)-pyrimidine; (A114) 4-(4-Bromo-2-fluoro-phenoxy)-5-nitro-6-(4-propy)-piperidin-1-yl)-pyrimidine; (A115) 3'-Nitro-2'-[4-(3-oxo-butyl)-phenoxy]-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-4-carboxylic acid ethyl ester; (A116) 4-[4-(3'-Nitro-4-propyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-yloxy)-phenyl]-butan-2-one; (A117) 2'-(4-Benzoyl-phenoxy)-3'-nitro-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-4-carboxylic acid ethyl ester; (A118) 4-(4-{5-Nitro-6-[4-(pyridin-2-ylsulfanyl)-piperidin-1-yl]-pyrimidin-4-yloxy}-phenyl)-butan-2-one; (A119) [4-(3'-Nitro-4-propyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-yloxy)-phenyl]-phenyl-methanone; (A120) 4-(4-{5-Nitro-6-[4-(2-trifluoromethyl-phenoxy)-piperidin-1-yl]-pyrimidin-4-yloxy}-phenyl)-butan-2-one; (A121) 4-(4-{6-[4-(3-Methyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-5-nitro-pyrimidin-4-yloxy}-phenyl)-butan-2-one; (A122) (4-{6-[4-(3-Methyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-5-nitro-pyrimidin-4-yloxy}-phenyl)-phenyl-methanone; (A123) 1-{6-[4-(4-Fluoro-benzoyl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidine-4-carboxylic acid ethyl ester; (A124) (4-Fluoro-phenyl)-{4-[5-nitro-6-(4-propyl-piperidin-1-yl)-pyrimidin-4-yloxy]-phenyl}-methanone; (A125) 4-[4-(3-Methyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidine; (A126) 4-(4-Methoxymethyl-piperidin-1-yl)-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidine; (A127) 4-{4-[6-(4-Methoxymethyl-piperidin-1-yl)-5-nitro-pyrimidin-4-yloxy]-phenyl}-butan-2-one; (A128) 4-[4-(2-Methoxy-ethyl)-piperidin-1-yl]-6-(2-methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidine; (A129) 4-{4-[6-(4-Ethoxymethyl-piperidin-1-yl)-5-nitro-pyrimidin-4-yloxy]-phenyl}-butan-2-one; (A130) 4-(2,4-Difluoro-phenoxy)-5-nitro-6-[4-(pyridin-2-ylsulfanyl)-piperidin-1-yl]-pyrimidine; (A131) (4-Methoxy-2-{5-nitro-6-[4-(pyridin-2-ylsulfanyl)-piperidin-1-yl]-pyrimidin-4-yloxy}-phenyl)-phenyl-methanone; (A132) 4-(2,4-Difluoro-phenoxy)-6-(4-ethoxymethyl-piperidin-1-yl)-5-nitro-pyrimidine; (A133) 4-{4-[6-(4-Cyclopropylmethoxymethyl-piperidin-1-yl)-5-nitro-pyrimidin-4-yloxy]-phenyl}-butan-2-one; (A134) 4-{4-[5-Nitro-6-(4-propoxymethyl-piperidin-1-yl)-pyrimidin-4-yloxy]-phenyl}-butan-2-one; (A135) 1-{4-[6-(4-Methoxymethyl-piperidin-1-yl)-5-nitro-pyrimidin-4-yloxy]-phenyl}-ethanone; (A136) 4-{4-[2-Nitro-3-(4-propyl-piperidin-1-yl)-phenoxy]-phenyl}-butan-2-one; (A137) 1-{4-[2-Nitro-3-(4-propyl-piperidin-1-yl)-phenoxy]-phenyl}-ethanone; (A138) {4-[2-Nitro-3-(4-propyl-piperidin-1-yl)-phenoxy]-phenyl}-phenyl-methanone; (A139) 3-{4-[2-Nitro-3-(4-propyl-piperidin-1-yl)-phenoxy]-phenyl}-3-oxo-propionic acid methyl ester; (A140) 4-{4-[6-(4-Butoxymethyl-piperidin-1-yl)-5-nitro-pyrimidin-4-yloxy]-phenyl}-butan-2-one; (A141) 4-{4-[6-(4-lsobutoxymethyl-piperidin-1-yl)-5-nitro-pyrimidin-4-yloxy]-phenyl}-butan-2-one; (A142) (4-Fluoro-phenyl)-[4-(3'-nitro-4-propyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-yloxy)-phenyl]-methanone; (A143) 4-[4-(3'-Nitro-4-propyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-yloxy)-phenyl]-butan-2-one; (A144) 3'-Nitro-4-propyl-4'-(4-[1,2,4]triazol-1-yl-phenoxy)-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl; (A145) 1-{2-Nitro-3-[4-(3-oxo-butyl)-phenoxy]-phenyl}-piperidine-4-carboxylic acid ethyl ester; (A146) 1-[3-(4-Benzoyl-phenoxy)-2-nitro-phenyl]-piperidine-4-carboxylic acid ethyl ester; (A147) {4-[6-(4-Ethoxy-piperidin-1-yl)-5-nitro-pyrimidin-4-yloxy]-phenyl}-(4-fluoro-phenyl)-methanone; (A148) 1-[6-(2-Methyl-5-trifluoromethyl-2H-pyrazol-3-yloxy)-5-nitro-pyrimidin-4-yl]-piperidin-4-ol; (A149) 1-[6-(4-Acetyl-phenoxy)-5-nitro-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A150) (1-{6-[4-(4-Fluoro-benzoyl)-phenoxy]-5-nitro-pyrimidin-4-yl}-piperidin-4-yl)-(4-fluoro-phenyl)-methanone; (A151) 4-(4-{6-[4-(4-Fluoro-benzoyl)-piperidin-1-yl]-5-nitro-pyrimidin-4-yloxy}-phenyl)-butan-2-one; (A152) 4-(4-Methanesulfonyl-phenoxy)-5-nitro-6-[4-(pyridin-2-ylsulfanyl)-piperidin-1-yl]-pyrimidine; (A153) 4-(4-Methanesulfonyl-phenoxy)-5-nitro-6-[4-(pyridin-4-ylsulfanyl)-piperidin-1-yl]-pyrimidine; (A91) 4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-methanesulfonyl-phenoxy)-pyrimidine-5-carbonitrile; (A155) 1-[5-Nitro-6-(4-trifluoromethylsulfanyl-phenoxy)-pyrimidin-4-yl]-piperidine-4-carboxylic acid ethyl ester; (A156) 5-[1,3]Dioxolan-2-yl-4-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-methanesulfonyl-phenoxy)-pyrimidine; (A157) 4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-methanesulfonyl-phenoxy)-pyrimidine-5-carbaldehyde; (A158) 5-[1,3]Dioxolan-2-yl-4-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-[1,2,3]thiadiazol-4-yl-phenoxy)-pyrimidine; (A159) 4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-[1,2,3]thiadiazol-4-yl-phenoxy)-pyrimidine-5-carbaldehyde; (A161) [4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-[1,2,3]thiadiazol-4-yl-phenoxy)-pyrimidin-5-yl]-methanol; (A162) [4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-[1,2,3]thiadiazol-4-yl-phenoxy)-pyrimidin-5-ylmethyl]-dimethyl-amine; (A154) 4-(4-Methanesulfonyl-phenoxy)-5-nitro-6-(4-phenylsulfanyl-piperidin-1-yl)-pyrimidine; (A163) 4-[4-(3-tert-Butyl-[1,2,4joxadiazol-5-yl)-piperidin-1-yl]-6-(6-methanesulfonyl-pyridin-3-yloxy)-5-nitro-pyrimidine; (A164) 4-[4-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-6-(4-methanesulfonyl-phenoxy)-2-methyl-pyrimidine-5-carbonitrile; and (A165) 1-[4-[4-(3-Isopropyl-[1,2,4]oxadiazoi-5-yl)-piperidin-1-y1]-6-(4-methanesulfonyl-phenoxy)-pyrimidin-5-yl]-ethanone.

Last Update: 2014-12-05
Usage Frequency: 1
Quality:

Reference: MatteoT

German

Adaptives Gruppenantennensystem nach Anspruch 1, wobei ein mit einem jeweiligen Antennenelement (A1011-A101n) gekoppelter Teiler (A1021-A102n) vorgesehen ist, um ein Signal des Antennenelements (A1011-A101n) auf den Gewichtskombinierer (A103) und die Gewichtssteuerung (A104) aufzuteilen.

English

An adaptive array antenna system according to claim 1, wherein a divider (A1021-A102n) coupled with a respective antenna element (A1011-A101n) is provided for dividing a signal of said antenna element (A1011-A101n) to said weight combiner (A103) and said weight control (A104).

Last Update: 2014-12-05
Usage Frequency: 1
Quality:

Reference: MatteoT

German

Verfahren nach einem der Ansprüche 6 bis 10, dadurch gekennzeichnet, dass das Vorbereiten (A) eine Etappe Trocknen (A102, A115) beinhaltet.

English

Process of any of claims 6 to 10, characterised in that the preparation (A) comprises a drying step (A102, A115).

Last Update: 2014-12-05
Usage Frequency: 1
Quality:

Reference: MatteoT

German

Sichtlinien-Erfassungseinrichtung nach Anspruch 1 oder 2, ferner umfassend eine Fotometrieeinrichtung (10, A102), welche eine Lichtmenge mißt, die im wesentlichen auf den Augapfel des Betrachters einfällt, wobei die Bereichfestlegeeinrichtung eine Anzahl von fotoelektrischen Umwandlungselementen jedes Bereichs in Übereinstimmung mit den Ergebnissen der Messung durch die Fotometrieeinrichtung ändert.

English

A line-of-sight detecting device according to Claims 1 and 2, further comprising photometry means (10, A102) for metering a quantity of light substantially incident upon the eyeball of the viewer, wherein said area setting means changes a number of photoelectric conversion elements of each area in accordance with the results of metering by said photometry means.

Last Update: 2014-12-05
Usage Frequency: 1
Quality:

Reference: MatteoT

German

Sichtlinien-Erfassungseinrichtung nach Anspruch 6, ferner umfassend eine Fotometrieeinrichtung (10, A102) zum Messen einer Lichtmenge, die im wesentlichen auf den Augapfel des Betrachtes einfällt, wobei die Auswahleinrichtung eine Bereichfestlegung aus der Vielzahl von Bereichfestlegungen in Übereinstimmung mit den Ergebnissen der Messung durch die Fotometrieeinrichtung auswählt.

English

A line-of-sight detecting device according to Claim 6, further comprising photometry means (10, A102) for metering a quantity of light substantially incident upon the eyeball of the viewer, wherein said selection means selects one area setting from said plurality of area settings in accordance with the results of metering by said photometry means.

Last Update: 2014-12-05
Usage Frequency: 1
Quality:

Reference: MatteoT

German

Beispiel 2: In einem 15 l Druckautoklaven wurden vorgelegt: 3.8 l vollentsalztes Wasser, 19.4 g Vinylsulfonat in 25 %-iger wäßriger Lösung, 3.2 g Fe-Ammoniumsulfat in 10 %-iger wäßriger Lösung, 84 g Aerosol A102 in 30 %-iger wäßriger Lösung, 83.5 g Genapol PF40 (Propylenoxid-Ethylenoxid-Copolymerisat der Hoechst AG) in 20 %-iger wäßriger Lösung, 49.0 g n-Butylacrylat und 429 g Vinylacetat.

English

EXAMPLE 2 The following were first introduced into a 15 l pressure autoclave: 3.8 1 of deionized water 19.4 g of vinylsulfonate in a 25% aqueous solution, 3.2 g of Fe-ammonium sulfate in a 10% aqueous solution, 84 g of Aerosol A102 in a 30% aqueous solution, 83.5 g of Genapol PF40 (propylene oxide/ethylene oxide copolymer from Hoechst AG) in a 20% aqueous solution, 49.0 g of n-butyl acrylate and 429 g of vinyl acetate.

Last Update: 2014-12-03
Usage Frequency: 1
Quality:

Reference: MatteoT

German

In dem zweiten Dosiergefäß wurden als Initiatordosierung 1.65 g hydroxymethansulfinsaures Natrium (Brüggolit) in 87 ml Wasser gelöst. In dem dritten, mit Rührer ausgestatteten Dosiergefäß wurden 56 ml Wasser, 4.31 g Genapol X360 (Isotridecylpolyglykolether der Hoechst AG) als 25 %-ige wäßrige Lösung, 1.85 g Aerosol A102 (Sulfobernsteinsäurehalbester der Cyanamid GmbH) als 30 %-ige wäßrige Lösung, 111 g t-Butylacrylat und 27.8 g Diacetonacrylamid emulgiert. Die Vorlage wurde unter Rühren auf 45°C aufgeheizt.

English

In the second metering vessel, 1.65 g of sodium hydroxymethanesulfinate were dissolved in 87 ml of water as an initiator dosage. In the third metering vessel fitted with a stirrer, 56 ml of water, 4.31 g of Genapol X360 (isotridecyl polyglycol ether from Hoechst AG) as a 25% aqueous solution, 1.85 g of Aerosol A102 (sulfosuccinic acid half-ester from Cyanamid GmbH) as a 30% aqueous solution, 111 g of t-butyl acrylate and 27.8 g of diacetone-acrylamide were emulsified. The material initially introduced was heated up to 450 stirring.

Last Update: 2014-12-03
Usage Frequency: 1
Quality:

Reference: MatteoT

Get a better translation with
4,401,923,520 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK